FDA Clearance Tracker · P000058-S099
Infuse TM Bone Graft/Medtronic lnterbody Fusion Device
Last checked: Nov 20, 2026Latest source record: Jul 28, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 28, 2026
Approved
Time to decision
90 days
Received Apr 29, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000058-S099
- Device name
- Infuse TM Bone Graft/Medtronic lnterbody Fusion Device
- Applicant
- Medtronic Sofamor Danek USA, Inc.
- Applicant location
- Memphis, TN
- Received
- Apr 29, 2026
- Decided
- Jul 28, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P000058
Device type
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
Approval to offer an alternatively configured Infuse Bone Graft kit in which the sterile water for injection (sWFI) vials, syringes, and needles have been removed from the kit, as well as minor labeling changes associated with this alternative kit configuration.
Source documents
Other decisions for Medtronic Sofamor Danek USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262572 · Decided Oct 29, 2026 · 94 days after receipt
Device type: Intervertebral Fusion Device With Bone Graft, Lumbar (MAX) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.